Manufacturer's investigation conclusion: a specific cause for the reported end stage heart failure, renal dysfunction, hepatic dysfunction and subsequent patient outcome, as well as a direct correlation with the device, could not be determined through this evaluation.The account reported on (b)(6) 2020, that the patient expired due to end stage heart failure and non-ischemic cardiomyopathy contributed by acute chronic renal and liver failure.No additional information was provided by the account.The device was not returned for evaluation.The heartmate 3 instructions for use lists death, renal dysfunction, and hepatic dysfunction as adverse events that may be associated with the use of heartmate 3 left ventricular assist system.The relevant sections of the device history records were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
|